PPARγ activation alleviates oxidative stress and myocardial fibrosis by inhibiting the NF-κB axis and transforming growth factor-beta 1/suppressor of mothers against decapentaplegic (TGF-β1/Smad) pathways, thereby improving cardiac function (129, 130). This evidence concerns the gene PPARG and Myocardial fibrosis.